Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
20 a » 20 _ (Expand Search), 20 μ (Expand Search), 20 c (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
20 a » 20 _ (Expand Search), 20 μ (Expand Search), 20 c (Expand Search)
-
961
Comparison of baseline characteristics of patients based on HOMA-IR modifications after treatment (those in whom a decrease >20% was observed vs. all others).
Published 2018“…<p>Comparison of baseline characteristics of patients based on HOMA-IR modifications after treatment (those in whom a decrease >20% was observed vs. all others).</p>…”
-
962
-
963
-
964
-
965
-
966
-
967
-
968
-
969
-
970
-
971
validation of A20 target genes in hepatocytes.
Published 2011“…Each bar represents the mean±SE from 4–5 different animals. *p<0.05. <b>D)</b> Representative Oxyblot of rat primary hepatocytes transduced with rAd.A20 or rAd. βgal control adenovirus for 48 h and exposed to 60 minutes hypoxia (1% O2) followed by 120 minutes reoxygenation. …”
-
972
-
973
-
974
-
975
-
976
-
977
Drp1<sup>SD</sup> overexpression in Opa1 or Marf depleted type II NBs rescues the reduced mitochondrial membrane potential.
Published 2022“…<i>pnt</i>-Gal4, mCD8-GFP (+/+, 17 type II NBs, 8 brains), Drp1<sup>SD</sup> (9,5), <i>opa1</i> RNAi (16,5), Drp1<sup>SD</sup>;<i>opa1</i> RNAi (11,4), <i>marf</i> RNAi (11,5), Drp1<sup>SD</sup>;<i>marf</i> RNAi (7,4). …”
-
978
-
979
-
980
Overexpression of wild-type and mutant ALDH3A1 retards hTCEpi cell proliferation.
Published 2016“…After 4 d, cells were trypsinized and viable cells were counted using trypan blue exclusion on a hemocytometer. Consecutively, 2.0 x 10<sup>5</sup> cells were transferred to a new dish and this process repeated for a total of 8 passages, i.e., for 32 d until treated cells showed decreasing cell numbers. …”